Skip to main content

Myth: Intravenous iron may be hazardous in infected hemodialysis patients

  • Chapter
Myths and Shibboleths in Nephrology
  • 82 Accesses

Abstract

Iron stores become depleted in ESRD patients on hemodialysis due to a variety of reasons including hemolysis during dialysis and blood loss into the dialyzer and tubing. Iron deficiency is assessed by measuring serum ferritin, serum iron, and/or transferrin TSAT (transferrin saturation = total iron/TIBC × 100). Free iron is not detectable in vivo as long as transferrin is less than fully saturated. Serum ferritin is a labile marker affected by chronic infection and inflammation. Also, generally speaking, serum ferritin is a more useful gauge of iron status at lower values than at higher ones. A high serum ferritin level is associated with altered chemotactic and phagocytic properties of neutrophils, thereby reducing their ability to kill invading pathogens. However, unanswered is the question of whether serum ferritin levels are elevated due to increased iron stores or infection. Infection, per se, may elevate serum ferritin levels inducing neutrophil dysfuntion. When studies control for covariates, such as use of catheters and previous infections, the purported infectious risk associated with iron administration or elevated serum ferritin levels is reduced or eliminated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hoen B. Iron and infection: clinical experience. Am J Kidney Dis. 1999;34(Supplement 2):S30–S34.

    Article  PubMed  CAS  Google Scholar 

  2. Fishbane S. Review of issues relating to iron and infection. Am J Kidney Dis. 1999;34(Supplement 2):S47–S52.

    Article  PubMed  CAS  Google Scholar 

  3. Sunder-Plassmann G, Patruta SI, Horl WH. Pathobiology of the role of iron in infection. Am J Kidney Dis. 1999;34(Supplement 2):S25–S29.

    Article  PubMed  CAS  Google Scholar 

  4. Seifert A, von Herrath D, Schaefer K. Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis. Q J Med. 1987;65(248):1015–1024.

    PubMed  CAS  Google Scholar 

  5. Boelaert JR, Cantinieaux BF, Hariga CF, Fondu PG. Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients. Nephrol Dial Transplantation. 1990;5:504–517.

    Article  CAS  Google Scholar 

  6. Besarab A, Frinak S, Yee J. An indistinct balance: the safety and efficacy of parenteral iron therapy. J Am Soc Nephrol. 1999;10:2029–2043.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Haria, D.M. (2002). Myth: Intravenous iron may be hazardous in infected hemodialysis patients. In: Friedman, E.A., Anees, I. (eds) Myths and Shibboleths in Nephrology. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0407-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-94-010-0407-7_10

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-0616-6

  • Online ISBN: 978-94-010-0407-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics